Same immunological pathogenesis of Behcet′s disease and spondyloarthropathy

doi:10.3877/cma.j.issn.1674-0785.2017.20.008

Abstract

Abstract:

Behcet′s disease (BD) and spondyloarthropathy (SpA) are common autoimmune diseases in the department of rheumatology and immunology. Although they overlap in clinical manifestations, laboratory examination, and treatment, the viewpoint that BD belongs to SpA has not been widely recognized. The increased incidence of BD with SpA and the extensive research in genetics and cytology suggest that BD and SpA have the same immunological pathogenesis. Therefore, BD and SpA have been regarded as MHC-I related diseases. In this paper, we discuss how BD and SpA share the same immunological pathogenesis.

Key words: Behcet′s disease, Spondyloarthropathy, MHC-I

Qianqian Chen, Xiaolan Fu, Junxia Li. Same immunological pathogenesis of Behcet′s disease and spondyloarthropathy[J]. Chinese Journal of Clinicians(Electronic Edition), 2017, 11(20): 2331-2334.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2017.20.008

https://zhlcyszz.cma-cmc.com.cn/EN/Y2017/V11/I20/2331

References 36

[1]	Moll JM, Haslock I, Macrae IF, et al. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter′s disease, the intestinal arthropathies, and Behçet′s syndrome [J]. Medicine (Baltimore), 1974, 53(5): 343-364.
[2]	Goyette P, Boucher G, Mallon D, et al. High-density mapping of the MHC identifies a shared role for HLA-DRB101: 03* in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis [J]. Nat Genet, 2015, 47(2): 172-179.
[3]	McGonagle D, Aydin SZ, Gül A, et al. ′MHC-I-opathy′-unified concept for spondyloarthritis and Behçet’s disease [J]. Nat Rev Rheumatol, 2015, 11(12): 731-740.
[4]	Saadoun D, Wechsler B, Terrada C, et al. Azathioprine in severe uveitis of Behçet′s disease [J]. Arthritis Care Res(Hoboken), 2010, 62(12): 1733-1738.
[5]	McGonagle D, Georgouli T. The importance of ′Mechnikov′s thorn′ for an improved understanding of 21st century medicine and immunology: a view from the eye [J]. Scand J Immunol, 2008, 68(2): 129-139.
[6]	Khan MA, Mathieu A, Sorrentino R, et al. The pathogenetic role of HLA-B27 and its subtypes [J]. Autoimmun Rev, 2007, 6(3): 183-189.
[7]	Gupta R, Debbaneh MG, Liao W. Genetic epidemiology of psoriasis [J]. Curr Dermatol Rep, 2014, 3(1): 61-78.
[8]	De Menthon M, Lavalley MP, Maldini C, et al. HLA-B51/B5 and the risk of Behçet′s disease: a systematic review and meta-analysis of case–control genetic association studies [J]. Arthritis Rheum, 2009, 61(10): 1287-1296.
[9]	Ombrello MJ, Kirino Y, de Bakker PI, et al. Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity [J]. Proc Natl Acad Sci U S A, 2014, 111(24): 8867-8872.
[10]	Wallace GR. HLA-B51 the primary risk in Behçet disease [J]. Proc Natl Acad Sci U S A, 2014, 111(24): 8706-8707.
[11]	Gül A1, Esin S, Dilsen N, et al. Immunohistology of skin pathergy reaction in Behçet′s disease [J]. Br J Dermatol, 1995, 132(6): 901-907.
[12]	Yan J, Parekh VV, Mendez-Fernandez Y, et al. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules [J]. J Exp Med, 2006, 203(3): 647-659.
[13]	Kirino Y, Bertsias G, Ishigatsubo Y, et al. Genome-wide association analysis identifies new susceptibility loci for Behçet′s disease and epistasis between HLA-B51 and ERAP1 [J]. Nat Genet, 2013, 45(2): 202-207.
[14]	Haliloglu T, Gul A, Erman B. Predicting important residues and interaction pathways in proteins using Gaussian network model: binding and stability of HLA proteins [J]. PLoS Comput Biol, 2010, 6(7): e1000845.
[15]	Guasp P, Alvarez-Navarro C, Gomez-Molina P, et al. The peptidome of the Behçet′s disease-associated HLA-B5101 includes two sub-peptidomes differentially shaped by ERAP1 [J]. Arthritis Rheumatol, 2016, 68(2): 505-515.
[16]	Seregin SS, Rastall DP, Evnouchidou I, et al. Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens [J]. Autoimmunity, 2013, 46(8): 497-508.
[17]	Jacques P, Lambrecht S, Verheugen E, et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells [J]. Ann Rheum Dis, 2014, 73(2): 437-445.
[18]	Savill J, Dransfield I, Gregory C, et al. A blast from the past: clearance of apoptotic cells regulates immune responses [J]. Nat Rev Immunol, 2002, 2(12): 965-975.
[19]	Ergun T, Gürbüz O, Harvell J, et al. The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behçet′s disease [J]. Int J Dermatol, 1998, 37(12): 929-933.
[20]	Melikoglu M, Uysal S, Krueger JG, et al. Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers [J]. J Immunol, 2006, 177(9): 6415-6421.
[21]	Heilborn JD, Nilsson MF, Kratz G, et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium [J]. J Invest Dermatol, 2003, 120(3): 379-389.
[22]	Mumcu G, Cimilli H, Karacayli U, et al. Salivary levels of antimicrobial peptides Hnp 1-3, Ll-37 and S100 in Behçet′s disease [J]. Arch Oral Biol, 2012, 57(6): 642-646.
[23]	Hatemi G, Bahar H, Uysal S, et al. The pustular skin lesions in Behçet′s syndrome are not sterile [J]. Ann Rheum Dis, 2004, 63(11): 1450-1452.
[24]	Mumcu G, Ergun T, Inanc N, et al. Oral health is impaired in Behçet′s disease and is associated with disease severity [J]. Rheumatology (Oxford), 2004, 43(8): 1028-1033.
[25]	Tascilar K, Melikoglu M, Ugurlu S, et al. Vascular involvement in Behçet′s syndrome: a retrospective analysis of associations and the time course [J]. Rheumatology(Oxford), 2014, 53(11): 2018-2022.
[26]	Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort [J]. Arthritis Rheum, 2009, 60(3): 717-727.
[27]	Wolf SE, Meenken C, Moll AC, et al. Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma [J]. BMC Cancer, 2013, 13: 561.
[28]	Alvarez-Navarro C, Martín-Esteban A, Barnea E, et al. Endoplasmic reticulum aminopeptidase 1(ERAP1) polymorphism relevant to inflammatory disease shapes the peptidome of the birdshot chorioretinopathy-associated HLA-A29: 02 antigen [J]. Mol Cell Proteomics, 2015, 14(7): 1770-1780.
[29]	Sahin Z, Bıcakcıgil M, Aksu K, et al. Takayasu′i arteritis is associated with HLA-B52, but not with HLA-B51, in Turkey [J]. Arthritis Res Ther, 2012, 14(1): R27.
[30]	Meguro A, Inoko H, Ota M, et al. Genetics of Behçet disease inside and outside the MHC [J]. Ann Rheum Dis, 2010, 69(4): 747-754.
[31]	Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet′s disease [J]. Nat Genet, 2010, 42(8): 698-702.
[32]	Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R–IL12RB2 and IL10 as Behçet′s disease susceptibility loci [J]. Nat Genet, 2010, 42(8): 703-706.
[33]	Winchester R, Minevich G, Steshenko V, et al. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype [J]. Arthritis Rheum, 2012, 64(4): 1134-1144.
[34]	Radouane A, Oudghiri M, Chakib A, et al. HLA-B27 allele associated to Behçet′s disease and to anterior uveitis in Moroccan patients [J]. Ann Biol Clin(Paris), 2011, 69(4): 419-424.
[35]	Cortes A, Pulit SL, Leo PJ, et al. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1 [J]. Nat Commun, 2015, 6: 7146.
[36]	Hughes T, Coit P, Adler A, et al. Identification of multiple independent susceptibility loci in the HLA region in Behçet′s disease [J]. Nat Genet, 2013, 45(3): 319-324.

Please choose a citation manager

Content to export